These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1535139)

  • 1. [Therapeutic efficacy of polyvalent immunoglobulins in autoimmune Lambert-Eaton's syndrome].
    Rose C; Hachulla E; Hurtevent JF; Auxenfants E; Hatron PY; Devulder B
    Presse Med; 1992 Apr; 21(16):766. PubMed ID: 1535139
    [No Abstract]   [Full Text] [Related]  

  • 2. Lambert-Eaton syndrome.
    Anand A
    Hosp Pract (Off Ed); 1993 Mar; 28(3):12. PubMed ID: 8444979
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
    Peterlin BL; Flood W; Kothari MJ
    J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
    Okada A; Koike H; Nakamura T; Motomura M; Sobue G
    Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using immunoglobulins in muscular disease treatment.
    Pul R; Stangel M
    Expert Opin Biol Ther; 2008 Aug; 8(8):1143-50. PubMed ID: 18613765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].
    Boutin E; Rey C; Romeu M; Pouget J; Franques J
    Rev Med Interne; 2013 Aug; 34(8):493-6. PubMed ID: 23759215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Remission of Lambert-Eaton syndrome over a 10-year period. Recurrence without evidence of tumor at autopsy].
    Ferroir JP; Hervier-Caen C; Reignier A; Nicolle MH; Guillard A
    Rev Neurol (Paris); 1989; 145(12):851-2. PubMed ID: 2616969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lambert-Eaton syndrome.
    Pascuzzi RM; Kim YI
    Semin Neurol; 1990 Mar; 10(1):35-41. PubMed ID: 2189179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up in infantile-onset lambert-eaton myasthenic syndrome.
    Portaro S; Parisi D; Polizzi A; Ruggieri M; Andreetta F; Bernasconi P; Toscano A; Rodolico C
    J Child Neurol; 2014 Sep; 29(9):NP58-61. PubMed ID: 24114606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment in Lambert-Eaton myasthenic syndrome.
    Maddison P
    Ann N Y Acad Sci; 2012 Dec; 1275():78-84. PubMed ID: 23278581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute respiratory insufficiency as onset form of Lambert-Eaton's syndrome associated with pulmonary small cell carcinoma].
    Jover F; Chiner E; Arriero JM; Signes-Costa J; Marco J; Izura V
    An Med Interna; 2002 May; 19(5):243-5. PubMed ID: 12108000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy.
    Bird SJ
    Neurology; 1992 Jul; 42(7):1422-3. PubMed ID: 1620360
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term follow-up of Lambert-Eaton syndrome treated with intravenous immunoglobulin.
    Muchnik S; Losavio AS; Vidal A; Cura L; Mazia C
    Muscle Nerve; 1997 Jun; 20(6):674-8. PubMed ID: 9149073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.